Building a precision medicine infrastructure at a national level: The Swedish experience
Cambridge Prisms: Precision Medicine · 2023 · 1
DOI: 10.1017/pcm.2023.3 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cambridge Prisms: Precision Medicine, online erschienen am 27.02.2023. Verfasst von Anders Edsjö und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Genetics, Pathology and Molecular Diagnostics, Office for Medical Services, Region Skåne, Lund, Sweden. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: VINNOVA.
Abstract (Originalsprache)
Precision medicine has the potential to transform healthcare by moving from one-size-fits-all to personalised treatment and care. This transition has been greatly facilitated through new high-throughput sequencing technologies that can provide the unique molecular profile of each individual patient, along with the rapid development of targeted therapies directed to the Achilles heels of each disease. To implement precision medicine approaches in healthcare, many countries have adopted national strategies and initiated genomic/precision medicine initiatives to provide equal access to all citizens. In other countries, such as Sweden, this has proven more difficult due to regionally organised healthcare. Using a bottom-up approach, key stakeholders from academia, healthcare, industry and patient organisations joined forces and formed Genomic Medicine Sweden (GMS), a national infrastructure for the implementation of precision medicine across the country. To achieve this, Genomic Medicine Centres have been established to provide regionally distributed genomic services, and a national informatics infrastructure has been built to allow secure data handling and sharing. GMS has a broad scope focusing on rare diseases, cancer, pharmacogenomics, infectious diseases and complex diseases, while also providing expertise in informatics, ethical and legal issues, health economy, industry collaboration and education. In this review, we summarise our experience in building a national infrastructure for precision medicine. We also provide key examples how precision medicine already has been successfully implemented within our focus areas. Finally, we bring up challenges and opportunities associated with precision medicine implementation, the importance of international collaboration, as well as the future perspective in the field of precision medicine.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Genetics, Pathology and Molecular Diagnostics, Office for Medical Services, Region Skåne, Lund, Sweden.
- Division of Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden.
- Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
- Clinical Genetics, Karolinska University Hospital, Solna, Sweden.
- Genomic Medicine Center Karolinska, Karolinska University Hospital, Stockholm, Sweden.
- Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden.
ORCID-Profile: Richard Rosenquist
Förderung
- VINNOVA
Zitieren
APA
Edsjö, A., Lindstrand, A., Gisselsson, D., Mölling, P., Friedman, M., Cavelier, L., Johansson, M., Ehrencrona, H., Fagerqvist, T., Strid, T., Lovmar, L., Jacobsson, B., Johansson, Å., Engstrand, L., Wheelock, C. E., Sikora, P., Wirta, V., Fioretos, T., Rosenquist, R., & Genomic Medicine Sweden (GMS) (2023). Building a precision medicine infrastructure at a national level: The Swedish experience. Cambridge Prisms: Precision Medicine, 1. https://doi.org/10.1017/pcm.2023.3
Vancouver
Edsjö A, Lindstrand A, Gisselsson D, Mölling P, Friedman M, Cavelier L, et al. Building a precision medicine infrastructure at a national level: The Swedish experience. Cambridge Prisms: Precision Medicine. 2023;1. doi:10.1017/pcm.2023.3
BibTeX
@article{Edsj2023,
author = {Edsjö, Anders and Lindstrand, Anna and Gisselsson, David and Mölling, Paula and Friedman, Mikaela and Cavelier, Lucia and Johansson, Maria and Ehrencrona, Hans and Fagerqvist, Therese and Strid, Tobias and Lovmar, Lovisa and Jacobsson, Bo and Johansson, Åsa and Engstrand, Lars and Wheelock, Craig E and Sikora, Per and Wirta, Valtteri and Fioretos, Thoas and Rosenquist, Richard and Genomic Medicine Sweden (GMS), Genomic Medicine Sweden (GMS)},
title = {Building a precision medicine infrastructure at a national level: The Swedish experience},
journal = {Cambridge Prisms: Precision Medicine},
year = {2023},
volume = {1},
doi = {10.1017/pcm.2023.3}
}
EUVIMED